Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5712107 | 0.76 | S100A4 (0.58) | S100A4 | |
| SCHEMBL29481018 | 0.76 | S100A4 (0.58) | S100A4 | |
| SCHEMBL933891 | 0.73 | S100A4 (0.63) | S100A4 | |
| Hydrochloric Acid SCHEMBL1005321 | 0.70 | S100A4 (0.60) | S100A4 | |
| SCHEMBL3898948 | 0.69 | ALDH1A1 (0.39) | S100A4 | |
| SCHEMBL11899801 | 0.69 | ALDH1A1 (0.39) | S100A4 | |
| SCHEMBL3141116 | 0.67 | S100A4 (0.63) | S100A4 | |
| SCHEMBL9509774 | 0.65 | S100A4 (0.43) | S100A4 | |
| SCHEMBL11701230 | 0.64 | ADORA2A (0.71) | S100A4 | |
| SCHEMBL2883867 | 0.64 | S100A4 (0.60) | S100A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-02-26 | — | — | US | claimed |
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | C5, CCNE1, QSOX1 | S100A4 1343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.